Overview
Updated 14 Jul 2026
Vivek Subbiah is Professor of Medicine (Oncology) and Professor of Pediatrics (Hematology/Oncology) at Stanford University School of Medicine / Stanford Cancer Institute (Division of Oncology, Department of Medicine). The public record shows 1,434 publications with 32,217 citations (h-index 79), centered on Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Sarcoma Diagnosis and Treatment. It also documents an investigator role on 13 registered clinical trials.
- Most recent indexed publication: 2026 · Cancer biotherapy & radiopharmaceuticals
- Top research focus: Cancer Genomics and Diagnostics
- 13 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 142 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 405.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
Sponsor: PMV Pharmaceuticals, Inc
InvestigatorPhase 1RecruitingNCT07372625 - Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2Active, not recruitingNCT06400225 - TCF-001 TRACK (Target Rare Cancer Knowledge) Study
Sponsor: TargetCancer Foundation
InvestigatorRecruitingNCT04504604
Industry payments
43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Personalized Radionuclide Therapy via Avidin-Biotin Pretargeting: Biodistribution and Dosimetry of (177)Lu-DOTA-biotin with AvidinOX™ in Solid Tumors.
Cancer biotherapy & radiopharmaceuticals
2026 - Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation.
Journal of clinical oncology
2026 - Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment.
JCO precision oncology
2026
Most-cited worksby citation count (OpenAlex)
- 01Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations1,735 citations2015
- 02
- 03
- 04Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers776 citations2020
- 05The next generation of evidence-based medicine530 citations2023
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- Combined residency in Internal Medicine and Pediatrics
Case Western Reserve University / MetroHealth, Cleveland, Ohio, completed 2008
2008verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - MD
Sri Ramachandra Institute of Higher Education (formerly Sri Ramachandra Medical College and Research Institute), India
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scri.com ↗
Editorial & leadership rolesjournal and society appointments
- Co-Chair
'Advances in Precision Oncology' Clinical Trials Mini Symposium, AACR Annual Meeting 2026
2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Member
ESMO Precision Oncology Working Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Leadership/committee involvement in ASCO
AACR, and ESMO (tumor-agnostic precision oncology programming)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- Former: Associate Professor
Department of Investigational Cancer Therapeutics, and Medical Director, Clinical Center for Targeted Therapy, UT MD Anderson Cancer Center
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Media & interviewspress, podcasts and appearances
- Host
JAMA Oncology podcast episode with Dr. Michael Postow (Memorial Sloan Kettering) on immunotherapy for melanoma brain metastases (AMA Ed Hub platform)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - Featured video/commentary contributor
OncLive (tissue-agnostic therapies, precision oncology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Featured interview
AJMC - "AI Should Support Clinicians, Not Replace Them" (Patient-Centered Oncology Care conference)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/vivek-subbiah-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Instagram
instagram.com/viveksubbiahmd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/in/vivek-subbiah-md-bb968633
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
esmo.org/about-esmo/biographies/vivek-subbiah
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗ - Other
onclive.com/authors/vivek-subbiah-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Pasi Janne, MD, PhD
Harvard University
- 2,385
- publications
- 163
- h-index
- 15
- trials
Julie Brahmer, MD
Bloomberg (United States)
- 855
- publications
- 116
- h-index
- 12
- trials
Enriqueta Felip, MD, PhD
Hebron University
- 1,460
- publications
- 129
- h-index
- 8
- trials
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
- 2,643
- publications
- 148
- h-index
- 8
- trials